INHIBITEX, INC. (INHX) [Rocket]

In millions, except per share items	Dec-31-10	Dec-31-09	Dec-31-08	Dec-31-07	Dec-31-06	Dec-31-05	Dec-31-04	Dec-31-03
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenue:
License fees and milestones				1.7	0.2	0.2	0.2	0.2
Collaborative research and development.				1.1	0.5	0.5	0.5	0.6
Total revenue	1.9	1.2	3.2	10.0	23.4	34.5	22.8	19.0
Total revenue growth	61.9%	-63.5%	-68.6%	-57.2%	-32.0%	51.2%	20.0%	21.6%
Operating expense:
General and administrative				6.3	12.8	7.4	4.3	4.6
Total operating expense				38.9	12.8	7.4	4.3	4.6
Loss from operations.				-46.1	-35.3	-40.9	-26.4	-22.7
Operating margin				-460.1%	-150.9%	-118.8%	-116.0%	-119.3%
Other income (loss), net				2.0	1.1
Interest income, net				2.7	3.1	2.4	0.4	0.0
Net loss				-41.5	-31.1	-38.6	-25.9	-22.3

Basic and diluted net loss per share				($1.22)	($1.03)	($1.43)	($2.52)	($54.19)

Weighted average shares used to compute basic and diluted net loss per share				34.0	30.3	0.0	0.0	0.0